RQM+ Acquires Germany-Based CRO Kottmann

Kohlberg Acquires Majority Stake in Worldwide Clinical Trials

August 7, 2023

Healthcare Services

An affiliate of Kohlberg & Company agreed to acquire a majority stake in Worldwide Clinical Trials, a global contract research organization (CRO) headquartered in Research Triangle Park, North Carolina. The transaction is a recapitalization in which prior investor TJC, L.P. retains a meaningful minority equity stake; terms were not disclosed. Kohlberg will partner with Worldwide's management (Matt Jennings to become chairman) to support continued growth of the company's clinical trial and bioanalytical capabilities.

RQM+ Acquires Libra Medical

May 10, 2023

Healthcare Services

RQM+, a global MedTech regulatory and clinical services provider, has acquired Libra Medical, a contract research organization (CRO) specializing in early-stage clinical trials for complex medical devices and diagnostics. The acquisition expands RQM+'s clinical trial capabilities—particularly first-in-human (FIH) studies, regulatory affairs and quality assurance—and brings Libra's founder, Dr. Sew-Wah Tay, into RQM+ to continue client relationships.

RQM+ (Linden Capital) Acquires Jordi Labs

September 7, 2022

Healthcare Services

RQM+, a MedTech CRO and portfolio company of Linden Capital Partners, has acquired Jordi Labs, a specialist analytical chemistry and laboratory testing provider serving medical device and pharmaceutical customers. The deal strengthens RQM+'s lab services and extractables & leachables capabilities to support regulatory submissions and product development; Harris Williams advised Jordi Labs on the transaction.

RQM+ Acquires AcKnowledge Regulatory Strategies

January 4, 2022

Healthcare Services

RQM+ Corp. acquired AcKnowledge Regulatory Strategies, a San Diego-based regulatory affairs consultancy specializing in medical device and IVD submissions. The add-on expands RQM+’s FDA submission expertise and regulatory capabilities, bringing the AcKnowledge team and founder Allison Komiyama into RQM+’s network; RQM+ is backed by Linden Capital Partners.

Rho Acquires Dokumeds

December 8, 2021

Healthcare Services

Rho, a privately held full-service contract research organization (CRO) based in Research Triangle Park/Durham, North Carolina, has acquired Dokumeds, a privately held European CRO headquartered in Riga, Latvia. The acquisition expands Rho's global footprint and clinical development capabilities, providing clients broader access to patients and multinational trial support; terms were not disclosed.

Linden Capital Partners Acquires Majority Stake in RQM+

August 16, 2021

Medical Devices

Chicago-based Linden Capital Partners completed a majority investment in RQM+ (headquartered in Monroeville, Pennsylvania), partnering with the company’s founders and management to accelerate growth and expand regulatory, quality, and compliance services for medical device and IVD manufacturers. The transaction represents a sale by prior investors DFW Capital Partners and Chartwell/Chief Capital and will support organic growth and acquisitions to broaden RQM+’s service offerings.